Skip to main content
Equibles

BNTX · BioNTech SE · Metrics

Track BNTX — free

Use BNTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BNTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$85.60 +0.56 (+0.66%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$21.22B
Shares
247.93M
Volume · Nov 13 844.86K Avg daily vol (3M) 1.23M

BNTX metrics

58 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$85.60
Market cap
$21.22B

Price action

23 metrics
Price change (1W)
-2.2%
Price change (30D)
-5.1%
Price change (3M)
-8.0%
Price change (6M)
-4.4%
Price change (YTD)
-10.1%
Price change (1Y)
-17.6%
Trailing year
Price change (5Y)
-64.1%
52-week high
$119.34
52-week low
$83.89
Change from 52-week high
-28.3%
Change from 52-week low
+2.0%
Annualized volatility
46.7%
Annualized volatility (3M)
58.6%
Implied volatility (30D)
40.7%
IV rank (1Y)
39.0
IV percentile (1Y)
32.5
Beta
1.0
RSI (14D)
40.4
Price vs SMA 50
-8.0%
Price vs SMA 200
-10.6%
Avg volume (3M)
1.23M
Relative volume
0.7
Average dollar volume
$121.74M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
247.93M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.1
reciprocal yield 94.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2022-06-02

Earnings calendar

2 metrics
Next earnings
2027-03-02
Last earnings
2026-11-03

Profitability

9 metrics
Gross margin
77.6%
Operating margin
-49.0%
Trailing 12 months
Net margin
-39.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+4.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.7%
Year over year · more shares
Revenue CAGR (3Y)
-45.1%
Revenue CAGR (5Y)
+42.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-72.3%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-5.9%
Return on assets
-5.2%
Debt / equity
—
Current ratio
8.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
8.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$11.57B
Total assets
$22.89B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
284
13F filer change QoQ
+10
Institutional ownership
20.0%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.2%
Holder tenure
14.9
Price vs estimated holder cost
-14.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.0%

Short interest

3 metrics
Short interest
0.9%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$84.23M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 244 filings 217 filers Visit website Investor relations